title: Cognitive improvement with intrathecal administration of infliximab in a woman with Alzheimer's disease.
authors.forename: Jian-Quan
authors.initials: JQ
authors.lastname: Shi
authors.forename: Bian-Rong
authors.initials: BR
authors.lastname: Wang
authors.forename: Wei-Wei
authors.initials: WW
authors.lastname: Jiang
authors.forename: Jun
authors.initials: J
authors.lastname: Chen
authors.forename: Yin-Wei
authors.initials: YW
authors.lastname: Zhu
authors.forename: Ling-Ling
authors.initials: LL
authors.lastname: Zhong
authors.forename: Ying-Dong
authors.initials: YD
authors.lastname: Zhang
authors.forename: Jun
authors.initials: J
authors.lastname: Xu
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007278:Injections, Spinal; D008609:Mental Status Schedule; D008875:Middle Aged; D009483:Neuropsychological Tests; D010446:Peptide Fragments / Q000134:cerebrospinal fluid
chemical_list: D016229:Amyloid beta-Peptides; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D010446:Peptide Fragments; C078592:amyloid beta-protein (1-40); C075222:amyloid beta-protein (1-42); D000069285:Infliximab